Colistin dosing and nephrotoxicity in a large community teaching hospital. - Wikidata - awgldk - TriplyDB

Colistin dosing and nephrotoxicity in a large community teaching hospital.

Colistin dosing and nephrotoxicity in a large community teaching hospital.

http://www.wikidata.org/entity/Q34150958

about

Renal and neurological side effects of colistin in critically ill patients Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study.High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol The risk factors of colistin methanesulfonate associated nephrotoxicity.Evaluation of Risk Factors for Intravenous Colistin Use-related Nephrotoxicity Cell cycle arrest in a model of colistin nephrotoxicity.Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach.Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter?Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.Colistin: an update on the antibiotic of the 21st century.Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.Emergent renal dysfunction with colistin pharmacotherapy.Colistin: understanding and applying recent pharmacokinetic advances.Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.Colistin- and polymyxin-induced nephrotoxicity: focus on literature utilizing the RIFLE classification scheme of acute kidney injury.Adverse reactions associated with systemic polymyxin therapy.Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.A review on colistin nephrotoxicity.Colistin: efficacy and safety in different populations.Strategies for the safe use of colistin.The safety of polymyxin antibiotics.Good tolerability of high dose colistin-based therapy in patients with haematological malignancies.Use of Colistin in a Neonatal Intensive Care Unit: A Cohort Study of 65 Patients Recent advances and perspectives in the design and development of polymyxins.Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system.The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study.Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Is there really no benefit to combination therapy with colistin?

P2860

Q27499294-5216750D-9F01-448E-B662-D5386B656091 Q33751736-B468969C-0FB4-4CF7-B9AB-CBC0BAC1676D Q34437229-D7E44588-67EC-4843-B014-66EA6ABA06CC Q34955582-48677FF6-7535-41F7-BC0F-119E794008FE Q34994417-E7CC9C85-1851-4A5A-8447-AC08B9E48750 Q35065863-7D6FC468-8EAA-4A7A-A349-17DC9EAD55B2 Q35432770-D60F3B23-812D-40BB-B31F-333EEF7C49A9 Q35607925-557601BB-EF36-40E6-994D-C50A6AD406E2 Q35941403-CF8F4BDF-F32C-4BAE-832A-818DBDA4BF73 Q36171772-3C5397F9-F516-4C2F-A517-92B09B7AFD42 Q36276852-5600EEAB-A34D-40F8-934E-3EBA690345DE Q36299428-E0EFB394-1779-48E4-A432-B170B760B984 Q36730174-58C31290-9ED8-479B-81A0-FD46DBE05A04 Q36818945-E9F90D06-3B72-466E-861D-DE2376A97038 Q37041117-D14E8FBC-5C8E-4FCD-B644-C6E0FF2C6D8F Q37053617-162E0CDD-30AA-4B92-B374-CE6DBF4CAC81 Q37234937-C1B24612-EBE7-4CF1-B202-E1BE1B27BBA8 Q37729344-D2C19C4E-37F2-454A-99E8-BB400ED1CBF6 Q37838126-FAE87BB5-7138-4668-99DD-D66F93876512 Q37869910-30D43739-4313-451C-883D-F2FCB60B85FB Q38019839-CD79A43C-D538-4C51-B6B0-A0EE8CFF1033 Q38048852-F79DB9C9-03BF-4DF9-997C-A29058724EE1 Q38097120-BB9CC29F-FB0E-4DCA-AC50-D45334196C54 Q38100749-2E643EF5-5CAD-4334-BCBE-D0D3529E9732 Q38246001-79DC708E-5F9C-432B-90AB-8C93E311B229 Q38247400-EC987F64-3A79-46CD-AA91-840CBAB1D18C Q38252561-2FC49DAB-B615-4615-A0FC-361F5132CD61 Q38255373-6B5030CD-E791-475F-8729-485A46A561AF Q38262205-C86D5C28-7870-428E-AB77-47FDA320190C Q38501685-1E9A7CCC-D4E5-4B8E-BDB1-8D702843DCB7 Q38514980-0F74E337-DB2E-44EF-835D-53C6D288430D Q38548658-ECA8DACE-2D8D-4E44-B451-B9C6BCFE0B24 Q38586123-9EAACAD4-9721-4537-844E-79B99DC659B5 Q38869608-2111DBA9-E88E-4015-9FF4-EA7F1E58C93C Q38992007-F5911DC2-57AB-4891-B613-A0921F8F4BC5 Q39190865-45CCE892-22A2-40FE-AE9F-9AE7701D598C Q39204542-EC59A2AE-512E-4A2B-B766-9E5EB26D5560 Q39236424-052563C6-983B-4085-BB98-0EE499B42180 Q39333751-EEC25EA3-A9B2-450D-B4D1-9BB27D926AE9 Q39347152-0F7C228A-7B36-4870-ABD2-EB01D678C192

P2860

Colistin dosing and nephrotoxicity in a large community teaching hospital.

http://www.wikidata.org/entity/Q34150958

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@ast

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@en

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@nl

type

label

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@ast

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@en

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@nl

prefLabel

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@ast

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@en

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@nl

P1433

Q34150958-37CB2378-2A7A-46E8-81C3-96DA8C124D2D

P1476

Q34150958-8A31A24E-8078-4668-8A31-78100B969870

P2093

Q34150958-4EF2E538-2B30-408E-97DD-B3E773497D7C

Q34150958-98E8FF16-004C-49D4-8C38-E8E82169CD9C

Q34150958-9DC25C77-B909-4A0F-B09A-7DD383CB741F

Q34150958-B4F0C663-139F-40D4-9302-5A05FF78D50B

P2860

Q34150958-117611B4-36C0-405F-9316-880013702F60

Q34150958-29405649-01DF-4AC4-BEB1-F22502395E63

Q34150958-3FB792B8-2F38-4B16-B43F-8293175F6465

Q34150958-4B96920F-0479-4B00-A1FF-C10D26D71486

Q34150958-67A06589-235A-49EC-BFB7-CEB0FB2819A1

Q34150958-97A87B33-4C01-4835-8C66-E044186F6262

Q34150958-A75B34FD-F376-4828-A66E-75F83CF9674C

Q34150958-A9246FB6-F5DC-4423-BB2A-0EFCC03BE751

Q34150958-BF745176-358A-45E7-AF79-66577E82066D

Q34150958-CDFCDBF0-60AA-44EB-BC95-F1DA19FDA1ED

P304

Q34150958-ED6714F9-51CD-4BC8-9F19-A5E0727D4BA7

P31

Q34150958-0A74ABD3-0C96-4DBE-A856-BEA4E0781942

P356

Q34150958-F8FAC6D9-9D18-41B5-A20B-F27806CC4AE3

P407

Q34150958-EB23CE84-56AF-43AB-AF7A-B8EA681ED489

P433

Q34150958-E3423BDC-EEF8-48C9-BFBD-E4829ACFFA14

P478

Q34150958-8C7E6CB9-EDE7-42C0-B322-A2DF003AB72F

P577

Q34150958-6D29F02A-0D2B-4ADC-BDE2-BA5565A0D748

P698

Q34150958-6E84F36F-48AD-47B9-B890-93F1898FDE1E

P932

Q34150958-7EDDEE73-A964-4ABA-9D94-B6AA919A6C36

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Colistin dosing and nephrotoxicity in a large community teaching hospital.

@en

P2093

Amanda J Crawford

http://www.w3.org/2001/XMLSchema#string

C Andrew Deryke

http://www.w3.org/2001/XMLSchema#string

Mark R Wallace

http://www.w3.org/2001/XMLSchema#string

Nizam Uddin

http://www.w3.org/2001/XMLSchema#string

P2860

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

APACHE II: a severity of disease classification system

Prediction of creatinine clearance from serum creatinine

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.

Colistin in the 21st century.

Nephrotoxicity of intravenous colistin: a prospective evaluation.

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

P304

4503-4505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01707-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20660694

http://www.w3.org/2001/XMLSchema#string

P932

2944569

http://www.w3.org/2001/XMLSchema#string